z-logo
Premium
Design and evaluation of radiolabeled tracers for tumor imaging
Author(s) -
Wållberg Helena,
Ståhl Stefan
Publication year - 2013
Publication title -
biotechnology and applied biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.468
H-Index - 70
eISSN - 1470-8744
pISSN - 0885-4513
DOI - 10.1002/bab.1111
Subject(s) - molecular imaging , computational biology , molecular probe , identification (biology) , biology , chemistry , biochemistry , gene , microbiology and biotechnology , in vivo , botany
The growing understanding of tumor biology and the identification of tumor‐specific genetic and molecular alterations, such as the overexpression of membrane receptors and other proteins, allows for personalization of patient management using targeted therapies. However, this puts stringent demands on the diagnostic tools used to identify patients who are likely to respond to a particular treatment. Radionuclide molecular imaging is a promising noninvasive method to visualize and characterize the expression of such targets. A number of different proteins, from full‐length antibodies and their derivatives to small scaffold proteins and peptide receptor‐ligands, have been applied to molecular imaging, each demonstrating strengths and weaknesses. Here, we discuss the concept of molecular targeting and, in particular, molecular imaging of cancer‐associated targets. Additionally, we describe important biotechnological considerations and desired features when designing and developing tracers for radionuclide molecular imaging.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here